That is very important, due to the fact that the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and work. In other words, we need to understand how these proteins fold if we want a drug to work. Historically, this has been an experimental process (exponential growth). Now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much simpler to create drugs that do what they're developed to do. This was an advancement almost no one saw. But it's going to have extensive ramifications for curing disease. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be a lot of financial investment chances in this space, too. Shifting subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (jeff brown top biotech 2020). That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it pulled back perhaps significantly before going higher - social media. I have actually been covering bitcoin for a very long time now. One of the first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were primarily educating readers. But that's not the big question any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So think about that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. jeff brown tech stock 2021. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are numerous terrific private business on the verge of striking the public markets And I've been dealing with a brand-new method for you to invest even before these business go public.
This opportunity has actually been constructing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the details. Go right here to schedule your area totally free.
Emma Walsh here, managing editor of the Journal. Regular Diary readers understand that tech isn't our usual beat (united arab emirates). And when it concerns tech investing, we leave it to the specialists. The good news is, we have a number of such specialists in our Rolodex. Our associate Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing specialists we understand (longtime readers). In truth, he had numerous triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the huge photo and forecast what's just around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and a lot more. These trends are experiencing exponential development and developing unbelievable opportunities for investors. I desire to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. black sea. But in spite of what numerous readers may believe, this is a trend that's just beginning. Although the COVID-19 pandemic interfered with supply chains last year, an excellent 250 million 5G-enabled devices were still sold.
And all of this ultimately resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (artificial intelligence). Losing two months of production and sales actually impacts the number of 5G gadgets are offered in the fiscal year. When you consider all of that, offering 250 million systems is amazing. More notably, the delays triggered by the pandemic created a lot of suppressed need. And that demand is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G devices will be delivered in 2021 - black sea. And that's not my only 5G forecast When I've discussed 5G in the past, I have actually described its 3 different stages.
In Stage 2, 5G devices go on sale. 5G phones and other products begin to reach customers. And in Stage 3, 5G services begin to be provided (jeff brown genome sequencing). That's when we start to see applications working on 5G networks. Believe of things like huge multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Stage 3 by this summertime. This starts something of a virtuous cycle: Many people don't actually appreciate the technology. However they will care if there are exciting applications that can just be accessed with a 5G phone.
That causes more 5G apps being developed. In truth, 5G is going to open up a suite of extraordinary applications: self-driving cars and trucks, the Internet of Things, robotic surgical treatment, and more. All of these technologies require 5G. The financial investment chances moving forward will be massive. Stepping far from 5G, the next important innovation I anticipate in 2021 is CRISPR genetic editing. CRISPR stands for "clustered routinely interspaced brief palindromic repeat." It's a mouthful. But it is among the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software.
The program can crash or not work properly. CRISPR uses a comparable concept but with our genetic code. "Typos" in our genome can result in illness. CRISPR can correct these "typos." For many years, CRISPR was mainly a specific niche technology that wasn't well comprehended. And during that time, there were actually only three companies running in this space. But things are changing. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're dealing with diseases and seeing that this innovation simply works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and providing incredible returns. This entire market is efficiently a greenfield opportunity.
There's room for numerous companies to exist in this space. jeff brown predictions for 2021. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that 2 or three more hereditary modifying business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its most current Alpha, Fold software application can accurately forecast the folding of a protein based entirely on its amino acid sequence with 92. 4% accuracy. That is essential since the method a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been a trial-and-error procedure. And now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're developed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however several drug therapies produced utilizing this innovation. This was among those breakthroughs that nearly no one observed. However it's going to have profound ramifications for treating disease. And, of course, there will be a lot of investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it pulled back possibly significantly prior to going greater. I've been covering bitcoin for a long period of time now. One of the very first research study reports I ever released was on bitcoin - jeff brown biotech stock. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my suggestion. However at the time of that preliminary recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
But no one is asking that question anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. korean actress. Mass, Mutual is a 150-year-old organization. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another benefit forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the info depends on date since February 2021, but we could not separately confirm this claim. Offered Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down a precise figure at this moment. Brown is best understood for his sage-like ability to select winning innovation stocks. He invested more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience offers him an excellent point of view on the market. He's always on the hunt for new chances, and he shares a lot of his finest choices in the Near Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an excellent track record as a stock-picker, and he successfully forecasted some of the greatest economic events of the past twenty years. Although he doesn't appear to release his choices to the general public, the service's success is a direct indication of Brown's stock-picking expertise. No one on Wall Street gets it right each time, however Jeff Brown's accurate predictions have actually earned him legions of dedicated fans. That states a lot about his ability. The Near Future Report is published by Brownstone Research study, a prominent monetary research publisher. Brownstone Research provides numerous research services with a wide array of expertises - brownstone research stock.
The business is also affiliated with Bonner & Partners, another well-respected research publisher - jeff brown stock predictions 2021. On its site, Brownstone says its objective is to provide retail investors with professional-grade research study: "For too long, the best investment research has actually not been available to specific financiers. It has been normally scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth customers. jeff brown genetic sequencing stock. The mission of Brownstone Research is to make that kind of exclusive research available to any financiers looking to acquire an edge in the markets. The goal is easy to deliver unique and successful investment research discovered no place else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also works as the company's Chief Investment Expert.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to use its clients. After years of stable success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a household name throughout most of America. If you know even a little bit about the marketplace, you know that he has a reputation as a King Midas of sorts. the legacy report predictions. Everything he touches turns to gold! Jeff is well aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge job.
In truth, Brown believes S.A.V. united arab emirates. might be "the most significant pattern of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be marrying two cutting-edge innovations: expert system and electric cars and trucks. Musk hopes the combination will help him develop the very first fully-autonomous, self-driving automobiles ever. It's absolutely nothing except the automotive industry's Holy Grail. As you understand, electrical automobiles and self-driving automobile stocks have actually been substantial this year, but the Wall Street machine has actually been big on hype without much tangible result. In spite of a drastic increase in competition over the past couple of years, Brown still thinks Musk has the best possibility of putting it all together.
tech might be the magic string that ties it all together. S.A.V. represents Shared Autonomous Automobile, and it might be the future of transport. Basically, this technology would permit you to lease your cars and truck as an autonomous, self-driving taxi when you're not utilizing it. You simply get out of the vehicle and press a button on an app that tells the cars and truck to "sign up with the fleet." Next thing you understand, you're unwinding on your couch while your car shuttles ride-sharers around town. Best of all, you get to keep a hefty piece of the profits. It sounds outrageous, but it might be closed than you believe.